As an example, due to recent study developments that shows a correlation of NLRP3 inflammasome activation in APP/PS1 transgenic mice, which is one of Alzheimer’s disease (AD) animal models37, it is possible to predict that fucoxanthin may be used to improve the pathological symptoms observed in the AD mice model, such as memory impairment. This evidence concerns the gene NLRP3 and early-onset autosomal dominant Alzheimer disease.